Furoyl and benzofuroyl pyrroloquinolones as potent and selective PDE5 inhibitors for treatment of erectile dysfunction

被引：29

作者：

Jiang, WQ ^{[1
]}

Sui, ZH ^{[1
]}

Macielag, MJ ^{[1
]}

Walsh, SP ^{[1
]}

Fiordeliso, JJ ^{[1
]}

Lanter, JC ^{[1
]}

Guan, JH ^{[1
]}

Qiu, YH ^{[1
]}

Kraft, P ^{[1
]}

Bhattacharjee, S ^{[1
]}

Craig, E ^{[1
]}

Haynes-Johnson, D ^{[1
]}

John, TM ^{[1
]}

Clancy, J ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ 08869 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2003年 / 46卷 / 03期

关键词：

D O I：

10.1021/jm0202573

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Synthesis of furoyl and benzofuroyl pyrroloquinolones as potent and selective PDE5 inhibitors was reported. Their in vitro potencies in inhibiting PDE5 and selectivity in inhibiting other PDE isozymes (PDE1-4 and PDE6) were evaluated. Some of these compounds are more potent than sildenafil with better selectivity toward PDE1 and PDE6. Incorporation of solublizing groups resulted in bioavailable analogues. Selected compounds showed in vivo efficacy in anesthetized dog model for penile erection.

引用

页码：441 / 444

页数：4

共 50 条

[21] The discovery of novel, potent and selective PDE5 inhibitors
Bi, YZ
Stoy, P
Adam, L
He, B
Krupinski, J
Normandin, D
Pongrac, R
Seliger, L
Watson, A
Macor, JE
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) : 2461 - 2464
[22] Psychological Predictors of PDE5 Inhibitors in Vasculogenic Erectile Dysfunction
Palmas, Artur
Pascoal, Patricia
Nobre, Pedro
INTERNATIONAL JOURNAL OF SEXUAL HEALTH, 2019, 31 : A568 - A568
[23] PDE5 INHIBITORS FAILURES IN ERECTILE DYSFUNCTION - WHAT ARE THE CAUSES?
Fedorova, Anna
Vykhodtcev, Sergei
Lukyanov, Andrey
JOURNAL OF SEXUAL MEDICINE, 2017, 14 (05): : E306 - E306
[24] PDE5 inhibitors: Is there more to come besides erectile dysfunction?
Stief, Christian
EUROPEAN UROLOGY, 2007, 52 (04) : 943 - 944
[25] Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction (vol 89, 103022, 2019)
Reddy, G. Lakshma
Dar, Mohd. Ishaq
Hudwekar, Abhinandan D.
Mahajan, Priya
Nargotra, Amit
Baba, Adil Manzoor
Nandi, Utpal
Wazir, Priya
Singh, Gurdarshan
Bharate, Sonali S.
Vishwakarma, Ram A.
Syed, Sajad Hussain
Sawant, Sanghapal D.
BIOORGANIC CHEMISTRY, 2019, 92
[26] Selective N-pyrimidinyl pyrroloquinolone PDE5 inhibitors as agents for treatment of male erectile dysfunction.
Jiang, WQ
Sui, ZH
Guan, JH
Macielag, MJ
Zhang, SY
Qiu, YH
Kraft, P
Bhattacharjee, S
Lombardi, E
Haynes-Johnson, D
John, TM
Clancy, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U56 - U56
[27] Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED
Boyle, CD
Xu, R
Asberom, T
Chackalamannil, S
Clader, JW
Greenlee, WJ
Guzik, H
Hu, YQ
Hu, ZY
Lankin, CM
Pissarnitski, DA
Stamford, AW
Wang, YG
Skell, J
Kurowski, S
Vemulapalli, S
Palamanda, J
Chintala, M
Wu, P
Myers, J
Wang, P
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2365 - 2369
[28] Continuous use of PDE5 inhibitors in the treatment of erectile dysfunction: New insights and opportunities
Maria Puigvert, Ana
Prieto, Rafael
Garcia, Ferran
REVISTA INTERNACIONAL DE ANDROLOGIA, 2018, 16 (01): : 28 - 33
[29] B-carboline as PDE5 inhibitors for treatment of male erectile dysfunction.
Guan, JH
Jiang, WQ
Sui, ZH
Macielag, MJ
Walsh, SP
Lanter, JC
Fiordeliso, JJ
Alford, VC
Qiu, YH
Patricia, K
Bhattacharjee, S
Lombardi, E
Haynes-Johnson, D
John, TM
Clancy, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U55 - U55
[30] Design and synthesis of furyl/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors
Zheng, Hongbo
Li, Lin
Sun, Bin
Gao, Yun
Song, Wei
Zhao, Xiaoyu
Gao, Yanhui
Xie, Zhiyu
Zhang, Nianzhao
Ji, Jianbo
Yuan, Huiqing
Lou, Hongxiang
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 30 - 38

← 1 2 3 4 5 →